Plus Therapeutics Inc. (PSTV) PT Raised to $20.50 at Ascendiant Capital
Tweet Send to a Friend
Ascendiant Capital analyst Edward Woo raised the price target on Plus Therapeutics Inc. (NASDAQ: PSTV) to $20.50 (from $20.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
